All articles by Saywah Mahmood
Saywah Mahmood was a data journalist working across GlobalData's media sites. She holds an MA in Interactive Journalism from City, University of London.
Saywah Mahmood
@saywhatsaywah
Exclusive: How ambitious are the emissions targets of pharma and biotech companies?
Pharmaceutical Technology analysed the emissions reduction targets of 1,138 companies to find out which are leading the way.
Africa has seen the largest growth in women’s health-related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
The Middle East has seen the largest growth in respiratory-related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
Asia-Pacific has seen the largest growth in oncology-related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
Asia-Pacific has seen the largest growth in metabolic disorders-related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
The Middle East has seen the largest growth in infectious disease-related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
Asia-Pacific has seen the largest growth in immunology related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
Asia-Pacific has seen the largest growth in haematological disorders related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
Africa has seen the largest growth in genito urinary system and sex hormones-related trials over the past decade
We’ve analysed 10 years’ worth of clinical trials data from GlobalData to pick out key geographic trends.
Robotics-related deals in the pharmaceutical industry increased in H1 2021
Robotics-related deals made up 0.6% of all deals announced in the pharma sector in H1 2021.